Natasha Giordano

Insider Reports History

Location
Houston, TX
Signature
/s/ Julio C. Esquivel as Attorney-In-Fact for Natasha Giordano
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Natasha Giordano:

Company Role Class Num Shares Value Price $ Report Date Ownership
PLx Pharma Inc. Chief Executive Officer, Director Common Stock 5,186 $18,944 $3.65 15 Mar 2022 Direct
Matinas BioPharma Holdings, Inc. Director Stock option (right to buy) 437,244 01 Nov 2023 Direct
PLx Pharma Inc. Chief Executive Officer, Director Stock Option (right to buy) 300,000 22 Feb 2022 Direct
ORAGENICS INC Director Non-Employee Director Option (Right to Buy) 125,000 11 Dec 2025 Direct

Insider Reports Filed by Natasha Giordano

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OGEN ORAGENICS INC 11 Dec 2025 2 $0 4 Director 15 Dec 2025, 16:49
OGEN ORAGENICS INC 01 Sep 2025 0 $0 3 Director 02 Sep 2025, 16:32
MTNB Matinas BioPharma Holdings, Inc. 01 Nov 2023 1 $0 4 Director 03 Nov 2023, 16:49
MTNB Matinas BioPharma Holdings, Inc. 14 Nov 2022 1 $0 4 Director 16 Nov 2022, 20:36
/report/000092189522000885-giordano-natasha-2022-03-15 PLx Pharma Inc. 15 Mar 2022 1 +$14,977 4 Chief Executive Officer, Director 16 Mar 2022, 08:35
/report/000092189522000661-giordano-natasha-2022-02-22 PLx Pharma Inc. 22 Feb 2022 1 $0 4 Chief Executive Officer, Director 24 Feb 2022, 19:13
MTNB Matinas BioPharma Holdings, Inc. 01 Nov 2021 1 $0 4 Director 02 Nov 2021, 16:22
/report/000092189521001976-giordano-natasha-2021-08-09 PLx Pharma Inc. 09 Aug 2021 1 $0 4 Chief Executive Officer, Director 11 Aug 2021, 09:01